P. Hertzman

The cost effectiveness of orlistat in a 1-year weight-management programme for treating overweight and obese patients in Sweden

P. Hertzman, 2012, PharmacoEconomics.

Impact of inhaled corticosteroids on acute asthma hospitalization in Sweden 1978 to 1991.

U. Gerdtham, B. Jönsson, G. Boman, 1996, Medical care.

Health economics of prevention of coronary heart disease and vascular events: a cost-effectiveness analysis based on the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

M. Buxton, N. Poulter, B. Jönsson, 2001, Journal of Human Hypertension.

Cost-Effectiveness of Budesonide Controlled Ileal Release (CIR) Capsules as Maintenance Therapy versus No Maintenance Therapy for Ileocaecal Crohn’s Disease in Sweden

Å. Danielsson, C. Florén, R. Löfberg, 1998, Clinical drug investigation.

The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991.

B. Lindgren, C. Löfdahl, L. Jacobson, 2000, Respiratory medicine.

An assessment of innovative pricing schemes for the communication of value: is price discrimination and two-part pricing a way forward?

K. Tolley, P. Hertzman, Paul Miller, 2018, Expert review of pharmacoeconomics & outcomes research.

Impact of inhaled corticosteroids on asthma hospitalization in Sweden

U. Gerdtham, B. Jönsson, G. Boman, 1996 .

Cost of sick leave for total hip replacement.

R. Johnsson, P. Hertzman, B. Lindgren, 1988, Acta Orthopaedica Scandinavica.

An assessment of innovative pricing schemes for the communication of value: is price discrimination and two-part pricing a way forward?

K. Tolley, P. Hertzman, Paul Miller, 2018, Expert review of pharmacoeconomics & outcomes research.